Table 1. Clinical data.
| Characteristic | Benign pulmonary diseases, n (%) | Malignant or borderline diseases, n (%) | P |
|---|---|---|---|
| Gender | 0.436 | ||
| Male | 64 (52.5) | 141 (57.1) | |
| Female | 58 (47.5) | 106 (42.9) | |
| Age (years) | 1.000 | ||
| ≤70 | 109 (89.3) | 221 (89.5) | |
| >70 | 13 (10.7) | 26 (10.5) | |
| Smoker | 0.090 | ||
| Smoker | 82 (67.2) | 143 (57.9) | |
| Non-smoker | 40 (32.8) | 104 (42.1) | |
| GGNs or nodules size (mm), n (%) | 0.436 | ||
| ≤8 | 50 (41.0) | 113 (45.7) | |
| >8 | 72 (59.0) | 134 (54.3) | |
| Number of lung GGNs or nodules, n (%) | 0.526 | ||
| ≤3 | 94 (77.0) | 182 (73.7) | |
| >3 | 28 (23.0) | 65 (26.3) | |
| GGNs or nodules | 0.566 | ||
| GGNs | 42 (34.4) | 94 (38.1) | |
| Nodules | 80 (65.6) | 153 (61.9) | |
| miRNA outcome | <0.001 | ||
| Negative | 108 (88.5) | 161 (65.2) | |
| Positive | 14 (11.5) | 86 (34.8) |
GGN, glass ground nodule.